Author:
Colleoni M, ,Litman H J,Castiglione-Gertsch M,Sauerbrei W,Gelber R D,Bonetti M,Coates A S,Schumacher M,Bastert G,Rudenstam C-M,Schmoor C,Lindtner J,Collins J,Thürlimann B,Holmberg S B,Crivellari D,Beyerle C,Neumann R L A,Goldhirsch A
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Aebi S, Gelber S, Castiglione-Gertsch M, Gelber RD, Collins J, Thurlimann B, Rudenstam CM, Lindtner J, Crivellari D, Cortes-Funes H, Simoncini E, Werner ID, Coates AS, Goldhirsch A for the International Breast Cancer Study Group (IBCSG) (2000) Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet 355: 1869–1874
2. Boccardo F, Rubagotti A, Amoroso D, Mesiti M, Romeo D, Sismondi P, Giai F, Genta F, Pacini P, Distante V, Bolognesi A, Aldrighetti D, Farris A (2000) Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group O2 Randomized Trial. J Clin Oncol 18: 2718–2727
3. Bonadonna G, Valagussa P, Zambetti M, Buzzoni R (1987) Milan adjuvant trials for stage I-II breast cancer. In Adjuvant Therapy of Cancer V Salmon SE (ed) pp 211–221., Orlando: Grune & Stratton
4. Bonetti M, Gelber RD (2000) A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data. Stat in Med 19: 2595–2609
5. Bonetti M, Gelber RD (2001) STEPP: Subsets analyses and patterns of treatment-covariate interactions in clinical trials. Dana-Farber Cancer Institute Department of Biostatistical Sciences Technical Report Number 583Z
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献